sulforaphane has been researched along with Lipidoses in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, Y | 1 |
| Zhou, S | 1 |
| Guo, H | 1 |
| Zhang, J | 1 |
| Ma, T | 1 |
| Zheng, Y | 1 |
| Zhang, Z | 1 |
| Cai, L | 1 |
1 other study available for sulforaphane and Lipidoses
| Article | Year |
|---|---|
Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Topics: AMP-Activated Protein Kinases; Animals; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabete | 2020 |